Induction Chemotherapy for Orbit Preservation in Sinonasal Squamous Cell Carcinoma.

IF 0.6 Q4 CLINICAL NEUROLOGY Journal of Neurological Surgery Reports Pub Date : 2021-09-29 eCollection Date: 2021-07-01 DOI:10.1055/s-0041-1736160
Gabriela Lilly, Mathew Geltzeiler
{"title":"Induction Chemotherapy for Orbit Preservation in Sinonasal Squamous Cell Carcinoma.","authors":"Gabriela Lilly,&nbsp;Mathew Geltzeiler","doi":"10.1055/s-0041-1736160","DOIUrl":null,"url":null,"abstract":"<p><p>Sinonasal squamous cell carcinoma (SNSCC) is a rare and aggressive malignancy which often presents at an advanced stage. The gold-standard treatment includes negative-margin surgical resection plus adjuvant therapy. In cases of orbital invasion, surgery requires orbital exenteration which can carry significant morbidity and result in decreased quality of life. In selected patients, induction chemotherapy (IC) can allow for orbit preservation without compromising oncologic outcomes. The available literature will be briefly discussed.</p>","PeriodicalId":44256,"journal":{"name":"Journal of Neurological Surgery Reports","volume":null,"pages":null},"PeriodicalIF":0.6000,"publicationDate":"2021-09-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/44/42/10-1055-s-0041-1736160.PMC8481003.pdf","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Neurological Surgery Reports","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1055/s-0041-1736160","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2021/7/1 0:00:00","PubModel":"eCollection","JCR":"Q4","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 1

Abstract

Sinonasal squamous cell carcinoma (SNSCC) is a rare and aggressive malignancy which often presents at an advanced stage. The gold-standard treatment includes negative-margin surgical resection plus adjuvant therapy. In cases of orbital invasion, surgery requires orbital exenteration which can carry significant morbidity and result in decreased quality of life. In selected patients, induction chemotherapy (IC) can allow for orbit preservation without compromising oncologic outcomes. The available literature will be briefly discussed.

Abstract Image

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
鼻窦炎鳞状细胞癌眼眶保留的诱导化疗。
鼻窦鳞状细胞癌(SNSCC)是一种罕见的侵袭性恶性肿瘤,通常出现在晚期。金标准治疗包括负切缘手术切除加辅助治疗。在眼眶侵犯的情况下,手术需要眼眶清除,这可能会带来显著的发病率,并导致生活质量下降。在选定的患者中,诱导化疗(IC)可以在不影响肿瘤预后的情况下保留眼眶。本文将简要讨论现有的文献。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
31
审稿时长
12 weeks
期刊最新文献
Epidermoid Cyst with Bilateral Premedullary Involvement Resected from Left Far-Lateral Approach. Comment on: Artificial-Intelligent Prediction Model of Occurrence of Cerebral Vasospasms Based on Machine-Learning. Letter to the Editor Regarding "The Effect of Preoperative Cabergoline on Prolactinoma Fibrosis: A Case Series". Microvascular Decompression: An Effective Approach for Trigeminal Neuralgia Caused by a Dolichoectatic Basilar Artery after Multiple Treatment Failures. Immunoglobulin D-Lambda Multiple Myeloma Initially Presenting in the Sphenoid Sinus, Orbital Apex, and Skull Base: A Systematic Review with a Case Report.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1